{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:34:25Z","timestamp":1794854065016,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.pnpbp.2024.111067","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T21:16:43Z","timestamp":1718918203000},"page":"111067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Causal association between plasma metabolites and neurodegenerative diseases"],"prefix":"10.1016","volume":"134","author":[{"given":"Ao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7571","key":"10.1016\/j.pnpbp.2024.111067_bb0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111067_bb0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/bcpt.13839","article-title":"Betaine-the dark knight of the brain","volume":"133","author":"Bhatt","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.pnpbp.2024.111067_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2023.103887","article-title":"Glutamine metabolism in diseases associated with mitochondrial dysfunction","volume":"126","author":"Bornstein","year":"2023","journal-title":"Mol. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111067_bb0020","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111067_bb0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases","volume":"55","author":"Chen","year":"2023","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111067_bb0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jclinepi.2014.09.005","article-title":"Cochran\u2019s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy","volume":"68","author":"Cohen","year":"2015","journal-title":"J. Clin. Epidemiol."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111067_bb0035","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the global burden of Disease study 2016","volume":"17","year":"2018","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111067_bb0040","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/alz.12074","article-title":"Metabolomics and incident dementia in older Chinese adults: the Shanghai aging study","volume":"16","author":"Cui","year":"2020","journal-title":"Alzheimers Dement."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.111067_bb0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0006-3223(98)00043-2","article-title":"Multiple correlations and Bonferroni\u2019s correction","volume":"44","author":"Curtin","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111067_bb0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tig.2019.12.002","article-title":"Omics in neurodegenerative disease: hope or hype?","volume":"36","author":"Diaz-Ortiz","year":"2020","journal-title":"Trends Genet."},{"issue":"5047","key":"10.1016\/j.pnpbp.2024.111067_bb0055","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1126\/science.1546291","article-title":"Socioeconomic status and psychiatric disorders: the causation-selection issue","volume":"255","author":"Dohrenwend","year":"1992","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111067_bb0060","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/jpet.110.170142","article-title":"Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3","volume":"335","author":"Duan","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"19","key":"10.1016\/j.pnpbp.2024.111067_bb0065","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2024.111067_bib182","doi-asserted-by":"crossref","DOI":"10.1177\/1178646918802282","article-title":"Analysis, Nutrition, and Health Benefits of Tryptophan","volume":"11","author":"Friedman","year":"2018","journal-title":"Int J Tryptophan Res."},{"issue":"D1","key":"10.1016\/j.pnpbp.2024.111067_bib183","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic acids research"},{"key":"10.1016\/j.pnpbp.2024.111067_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41467-019-13770-6","article-title":"Heritability estimates for 361 blood metabolites across 40 genome-wide association studies","volume":"11","author":"Hagenbeek","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111067_bb0075","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/alz.12468","article-title":"Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer\u2019s disease","volume":"18","author":"Horgusluoglu","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111067_bb0080","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-220050","article-title":"Investigating causal relations between circulating metabolites and Alzheimer\u2019s disease: a Mendelian randomization study","volume":"87","author":"Huang","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.pnpbp.2024.111067_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2019.10.014","article-title":"Brain and blood metabolome for Alzheimer\u2019s dementia: findings from a targeted metabolomics analysis","volume":"86","author":"Huo","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pnpbp.2024.111067_bb0095","doi-asserted-by":"crossref","first-page":"101.e111","DOI":"10.1016\/j.neurobiolaging.2020.09.025","article-title":"Herpes simplex virus and Alzheimer\u2019s disease: a Mendelian randomization study","volume":"99","author":"Kwok","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111067_bb0100","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ng.3809","article-title":"Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites","volume":"49","author":"Long","year":"2017","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111067_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11120860","article-title":"Plasma metabolite markers of Parkinson\u2019s disease and atypical parkinsonism","volume":"11","author":"Pathan","year":"2021","journal-title":"Metabolites"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111067_bb0110","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0895-4356(91)90155-3","article-title":"How independent are \u201cindependent\u201d effects? Relative risk estimation when correlated exposures are measured imprecisely","volume":"44","author":"Phillips","year":"1991","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111067_bb0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jalz.2016.08.003","article-title":"Association of blood lipids with Alzheimer\u2019s disease: a comprehensive lipidomics analysis","volume":"13","author":"Proitsi","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111067_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int. J. Epidemiol."},{"issue":"18","key":"10.1016\/j.pnpbp.2024.111067_bb0125","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s00018-015-1937-8","article-title":"Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease","volume":"72","author":"Takahashi","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111067_bb0130","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3233\/JAD-220632","article-title":"Photobiomodulation for hypertension and Alzheimer\u2019s disease","volume":"90","author":"Valverde","year":"2022","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111067_bb0135","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jalz.2017.11.012","article-title":"Circulating metabolites and general cognitive ability and dementia: evidence from 11 cohort studies","volume":"14","author":"van der Lee","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111067_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.111067_bb0145","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pnpbp.2024.111067_bb0150","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer's disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.pnpbp.2024.111067_bb0155","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fneur.2017.00719","article-title":"Application of metabolomics in Alzheimer\u2019s disease","volume":"8","author":"Wilkins","year":"2017","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111067_bb0160","first-page":"333","article-title":"Anthocyanins and their metabolites as therapeutic agents for neurodegenerative disease","volume":"8","author":"Winter","year":"2019","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111067_bb0165","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12967-022-03691-2","article-title":"Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study","volume":"20","author":"Xiao","year":"2022","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111067_bb0170","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ije\/dyaa241","article-title":"Systemic inflammatory regulators and risk of Alzheimer\u2019s disease: a bidirectional Mendelian-randomization study","volume":"50","author":"Yeung","year":"2021","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111067_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8010016","article-title":"RaMP: a comprehensive relational database of metabolomics pathways for pathway enrichment analysis of genes and metabolites","volume":"8","author":"Zhang","year":"2018","journal-title":"Metabolites"},{"issue":"3\u20134","key":"10.1016\/j.pnpbp.2024.111067_bb0180","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000381338","article-title":"Mendelian randomization versus path models: making causal inferences in genetic epidemiology","volume":"79","author":"Ziegler","year":"2015","journal-title":"Hum. Hered."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T04:52:49Z","timestamp":1723265569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":37,"alternative-id":["S0278584624001350"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111067","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causal association between plasma metabolites and neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111067"}}